BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 33425220)

  • 1. Novel PGC-1
    Zhang B; Tan Y; Zhang Z; Feng P; Ding W; Wang Q; Liang H; Duan W; Wang X; Yu S; Liu J; Yi D; Sun Y; Yi W
    Oxid Med Cell Longev; 2020; 2020():9187065. PubMed ID: 33425220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melatonin protects against the pathological cardiac hypertrophy induced by transverse aortic constriction through activating PGC-1β: In vivo and in vitro studies.
    Zhai M; Liu Z; Zhang B; Jing L; Li B; Li K; Chen X; Zhang M; Yu B; Ren K; Yang Y; Yi W; Yang J; Liu J; Yi D; Liang H; Jin Z; Reiter RJ; Duan W; Yu S
    J Pineal Res; 2017 Oct; 63(3):. PubMed ID: 28708271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardioprotection by the mitochondrial unfolded protein response requires ATF5.
    Wang YT; Lim Y; McCall MN; Huang KT; Haynes CM; Nehrke K; Brookes PS
    Am J Physiol Heart Circ Physiol; 2019 Aug; 317(2):H472-H478. PubMed ID: 31274354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac hypertrophy drives PGC-1α suppression associated with enhanced O-glycosylation.
    Brainard RE; Facundo HT
    Biochim Biophys Acta Mol Basis Dis; 2021 May; 1867(5):166080. PubMed ID: 33486096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Heme Oxygenase 1 in the Protective Effect of Caloric Restriction against Diabetic Cardiomyopathy.
    Waldman M; Nudelman V; Shainberg A; Zemel R; Kornwoski R; Aravot D; Peterson SJ; Arad M; Hochhauser E
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31100876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disruption of sarcolemmal ATP-sensitive potassium channel activity impairs the cardiac response to systolic overload.
    Hu X; Xu X; Huang Y; Fassett J; Flagg TP; Zhang Y; Nichols CG; Bache RJ; Chen Y
    Circ Res; 2008 Oct; 103(9):1009-17. PubMed ID: 18802029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resveratrol alleviates diabetic cardiomyopathy in rats by improving mitochondrial function through PGC-1α deacetylation.
    Fang WJ; Wang CJ; He Y; Zhou YL; Peng XD; Liu SK
    Acta Pharmacol Sin; 2018 Jan; 39(1):59-73. PubMed ID: 28770830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melatonin alleviates angiotensin-II-induced cardiac hypertrophy via activating MICU1 pathway.
    Yang Y; Du J; Xu R; Shen Y; Yang D; Li D; Hu H; Pei H; Yang Y
    Aging (Albany NY); 2020 Nov; 13(1):493-515. PubMed ID: 33259334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maintaining PGC-1α expression following pressure overload-induced cardiac hypertrophy preserves angiogenesis but not contractile or mitochondrial function.
    Pereira RO; Wende AR; Crum A; Hunter D; Olsen CD; Rawlings T; Riehle C; Ward WF; Abel ED
    FASEB J; 2014 Aug; 28(8):3691-702. PubMed ID: 24776744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Astragaloside IV protects against isoproterenol-induced cardiac hypertrophy by regulating NF-κB/PGC-1α signaling mediated energy biosynthesis.
    Zhang S; Tang F; Yang Y; Lu M; Luan A; Zhang J; Yang J; Wang H
    PLoS One; 2015; 10(3):e0118759. PubMed ID: 25738576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator-activated receptor gamma coactivator 1 alpha protects cardiomyocytes from hypertrophy by suppressing calcineurin-nuclear factor of activated T cells c4 signaling pathway.
    Liu XP; Gao H; Huang XY; Chen YF; Feng XJ; He YH; Li ZM; Liu PQ
    Transl Res; 2015 Nov; 166(5):459-473.e3. PubMed ID: 26118953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of heart failure by minimally invasive aortic constriction in mice: reduced peroxisome proliferator-activated receptor γ coactivator levels and mitochondrial dysfunction.
    Faerber G; Barreto-Perreia F; Schoepe M; Gilsbach R; Schrepper A; Schwarzer M; Mohr FW; Hein L; Doenst T
    J Thorac Cardiovasc Surg; 2011 Feb; 141(2):492-500, 500.e1. PubMed ID: 20447656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C1q-TNF-related protein-3 attenuates pressure overload-induced cardiac hypertrophy by suppressing the p38/CREB pathway and p38-induced ER stress.
    Zhang B; Zhang P; Tan Y; Feng P; Zhang Z; Liang H; Duan W; Jin Z; Wang X; Liu J; Gao E; Yu S; Yi D; Sun Y; Yi W
    Cell Death Dis; 2019 Jul; 10(7):520. PubMed ID: 31285424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of diabetic cardiomyopathy by caloric restriction is mediated by intracellular signaling pathways involving 'SIRT1 and PGC-1α'.
    Waldman M; Cohen K; Yadin D; Nudelman V; Gorfil D; Laniado-Schwartzman M; Kornwoski R; Aravot D; Abraham NG; Arad M; Hochhauser E
    Cardiovasc Diabetol; 2018 Aug; 17(1):111. PubMed ID: 30071860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CTRP3 alleviates mitochondrial dysfunction and oxidative stress injury in pathological cardiac hypertrophy by activating UPRmt via the SIRT1/ATF5 axis.
    Shi L; Tan Y; Zheng W; Cao G; Zhou H; Li P; Cui J; Song Y; Feng L; Li H; Shan W; Zhang B; Yi W
    Cell Death Discov; 2024 Jan; 10(1):53. PubMed ID: 38278820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of ALDH2 aggravates mitochondrial biogenesis disorder in cardiac myocytes induced by TAC.
    Xia G; Xu J; Chen M; Jin J; Wang X; Ye Y
    Biochem Biophys Res Commun; 2023 Jan; 639():189-196. PubMed ID: 36535138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PGC-1 alpha regulates expression of myocardial mitochondrial antioxidants and myocardial oxidative stress after chronic systolic overload.
    Lu Z; Xu X; Hu X; Fassett J; Zhu G; Tao Y; Li J; Huang Y; Zhang P; Zhao B; Chen Y
    Antioxid Redox Signal; 2010 Oct; 13(7):1011-22. PubMed ID: 20406135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SUMOylation of SIRT1 activating PGC-1α/PPARα pathway mediates the protective effect of LncRNA-MHRT in cardiac hypertrophy.
    Liu MY; Yue LJ; Luo YC; Lu J; Wu GD; Sheng SQ; Shi YQ; Dong ZX
    Eur J Pharmacol; 2022 Sep; 930():175155. PubMed ID: 35863508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53-PGC-1α pathway mediates oxidative mitochondrial damage and cardiomyocyte necrosis induced by monoamine oxidase-A upregulation: role in chronic left ventricular dysfunction in mice.
    Villeneuve C; Guilbeau-Frugier C; Sicard P; Lairez O; Ordener C; Duparc T; De Paulis D; Couderc B; Spreux-Varoquaux O; Tortosa F; Garnier A; Knauf C; Valet P; Borchi E; Nediani C; Gharib A; Ovize M; Delisle MB; Parini A; Mialet-Perez J
    Antioxid Redox Signal; 2013 Jan; 18(1):5-18. PubMed ID: 22738191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of miR-23a attenuates doxorubicin-induced mitochondria-dependent cardiomyocyte apoptosis by targeting the PGC-1α/Drp1 pathway.
    Du J; Hang P; Pan Y; Feng B; Zheng Y; Chen T; Zhao L; Du Z
    Toxicol Appl Pharmacol; 2019 Apr; 369():73-81. PubMed ID: 30831132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.